JY231 / Guangdong Second Provincial General Hospital, Shanxi Bethune Hospital - LARVOL DELTA

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia (clinicaltrials.gov) - P=N/A | N=20 | Recruiting | Sponsor: Affiliated Hospital of Guangdong Medical University | Not yet recruiting ➔ Recruiting

Enrollment open • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • B Cell Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia (clinicaltrials.gov) - P=N/A | N=20 | Not yet recruiting | Sponsor: Affiliated Hospital of Guangdong Medical University

New trial • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • B Cell Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology

JY-CT-24-005: JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE) (clinicaltrials.gov) - P1/2 | N=20 | Recruiting | Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

New P1/2 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus

JY-CT-23-001: JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia (clinicaltrials.gov) - P=N/A | N=20 | Recruiting | Sponsor: Shenzhen Genocury Biotech Co., Ltd.

New trial • B Cell Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology

JY231(JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia(B-ALL) (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

New P1 trial • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Oncology

JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Guangdong Second Provincial General Hospital

New P1 trial • Follicular Lymphoma • Hematological Malignancies • Indolent Lymphoma • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology